Hepatocyte growth factor and its receptor signalling complex as targets in cancer therapy

Anti-Cancer Agents in Medicinal Chemistry

Volumn 10, Issue 1, 2010, Pages 2-6

  Martin, Tracey A ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Angiogenesis; Cancer treatment; CMET; Hepatocyte growth factor; Imaging; Metastasis

Indexed keywords

3 [1 (2,6 DICHLORO 3 FLUOROPHENYL)ETHOXY] 5 [1 (4 PIPERIDINYL) 1H PYRAZOL 4 YL] 2 PYRIDINYLAMINE; ANTINEOPLASTIC AGENT; BETA CATENIN; E 7050; MESSENGER RNA; METHIONINE C 11; METHYLTRANSFERASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DN30; MONOCLONAL ANTIBODY MET4; MUC1 CYTOPLASMIC TAIL; MUCIN 1; NOTCH RECEPTOR; PAXILLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAC PROTEIN; RHO FACTOR; RPI 1; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SMYD3 PROTEIN; SPROUTY PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN C;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; AUTOCRINE EFFECT; CANCER DIAGNOSIS; CANCER GENETICS; CANCER THERAPY; CARCINOGENESIS; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; DOWN REGULATION; DRUG TARGETING; FIBROSARCOMA; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; LIVER CELL CARCINOMA; LUNG METASTASIS; LYMPHANGIOGENESIS; MEDULLOBLASTOMA; MOLECULAR IMAGING; PARACRINE SIGNALING; POSITRON EMISSION TOMOGRAPHY; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SARCOMA; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SOLID TUMOR; SOMATIC MUTATION;

EID: 77950838832     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871520611009010002     Document Type: Review

References (27)

1. Nakamura, T.; Nishizawa, T.; Hagiya, M.; Seki, T.; Shimonishi, M.; Sugimura, A.; Tashiro, K.; Shimizu, S. Molecular cloning and expression of human hepatocyte growth factor. Nature, 1989, 342(6248), 440-443 (Pubitemid 19277521)
2. Gherardi, E.; Stoker, M. Hepatocytes and scatter factor. Nature, 1990, 346(6281), 228. (Pubitemid 20227395)
3. (a) Jiang, W. G.; Davies, G.; Martin, T. A.; Parr, C.; Watkins, G.; Mansel, R. E.; Mason, M. D. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo. Int. J. Mol. Med., 2005, 16(4), 723-728
4. (b) Jiang, W. G.; Davies, G.; Martin, T. A.; Parr, C.; Watkins, G.; Mason, M. D.; Mokbel, K.; Mansel, R. E. Targeting matrilysin and its impact on tumour growth in vivo: the potential implications in breast cancer therapy. Clin. Cancer Res., 2005, 11(16), 6012-6019 (Pubitemid 41170333)
5. Kajiya, K.; Hirakawa, S.; Ma, B.; Drinnenberg, I.; Detmar, M. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J., 2005, 24(16), 2885-2895 (Pubitemid 43079892)
6. You, W. K.; McDonald, D. M. The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. BMB Rep., 2008, 41(12), 833-839
7. Wojcik, E. J.; Sharifpoor, S.; Miller, N. A.; Wright, T. G.; Watering, R.; Tremblay, E. A.; Swan, K.; Mueller, C. R.; Elliott, B. E. A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells. Oncogene, 2006, 25(19), 2773-2784
8. Giannini, G.; Noel, J. Constitutive hepatocyte growth factorreceptor( HGF-R)/Met tyrosine kinase activation is associated with cellular transformation independently of mutations within its tyrosine kinase and c-terminal domains. Mol. Biol. Cell, 2002, 13, 156A.
9. Kammula, U. S.; Kuntz, E. J.; Francone, T. D.; Zeng, Z.; Shia, J.; Landmann, R. G.; Paty, P. B.; Weiser, M. R. Molecular coexpression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumour stage and clinical outcome. Cancer Lett., 2007, 248(2), 219-228 (Pubitemid 46330555)
10. Kaposi-Novak, P.; Lee, J. S.; Gomez-Quiroz, L.; Coulouarn, C.; Factor, V. M.; Thorgeirsson, S. S. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J. Clin. Invest., 2006, 116(6), 1582-1595 (Pubitemid 43911012)
11. (a) Hiscox, S.; Jiang, W. G. Association of the HGF/SF receptor, cmet, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumour cells. Biochem. Biophys. Res. Commun., 1999, 261(2), 406-411 (Pubitemid 29392489)
12. (b) Davies, G.; Jiang, W. G.; Mason, M. D. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin. Cancer Res., 2001, 7(10), 3289-3297 (Pubitemid 32963856)
13. (c) Rasola, A.; Fassetta, M.; De Bacco, F.; D'Alessandro, L.; Gramaglia, D.; Di Renzo, M. F.; Comoglio, P. M. A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth. Oncogene, 2007, 26(7), 1078-1087 (Pubitemid 46272209)
14. Ye, M.; Hu, D.; Tu, L.; Zhou, X.; Lu, F.; Wen, B.; Wu, W.; Lin, Y.; Zhou, Z.; Qu, J. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Invest. Ophthalmol. Vis. Sci., 2008, 49(2), 497-504.
15. Bauer, T. W.; Somcio, R. J.; Fan, F.; Liu, W.; Johnson, M.; Lesslie, D. P.; Evans, D. B.; Gallick, G. E.; Ellis, L. M. Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells. Mol. Cancer Ther., 2006, 5(7), 1676-1682 (Pubitemid 44323235)
16. (a) Fischer, O. M.; Giordano, S.; Comoglio, P. M.; Ullrich, A. Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells. J. Biol. Chem., 2004, 279(28), 28970-28978 (Pubitemid 38915766)
17. (b) Hecht, M.; Schulte, J. H.; Eggert, A.; Wilting, J.; Schweigerer, L. The neurotrophin receptor TrkB cooperates with c- Met in enhancing neuroblastoma invasiveness. Carcinogenesis, 2005, 26(12), 2105-2115 (Pubitemid 41672198)
18. Stella, M. C.; Trusolino, L.; Pennacchietti, S.; Comoglio, P. M. Negative feedback regulation of Met-dependent invasive growth by Notch. Mol. Cell Biol., 2005, 25(10), 3982-3996 (Pubitemid 40617648)
19. Leibowitz-Amit, R.; Tsarfaty, G.; Abargil, Y.; Yerushalmi, G. M.; Horev, J.; Tsarfaty, I. Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumourigenicity by altering Met-HGF/SF signaling pathways. Cancer Res., 2006, 66(17), 8687-8697 (Pubitemid 44449185)
20. Herter, S.; Piper, D. E.; Aaron, W.; Gabriele, T.; Cutler, G.; Cao, P.; Bhatt, A. S.; Choe, Y.; Craik, C. S.; Walker, N.; Meininger, D.; Hoey, T.; Austin, R. J. Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem. J., 2005, 390(Pt 1), 125-136 (Pubitemid 41192238)
21. Kirchhofer, D.; Peek, M.; Lipari, M. T.; Billeci, K.; Fan, B.; Moran, P. Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B(HAI-1B) and HAI-2. FEBS Lett., 2005, 579(9), 1945-1950 (Pubitemid 40404036)
22. Zou, J. N.; Wang, S. Z.; Yang, J. S.; Luo, X. G.; Xie, J. H.; Xi, T. Knockdown of SMYD3 by RNA interference down-regulates c- Met expression and inhibits cells migration and invasion induced by HGF. Cancer Lett., 2009, 280(1), 78-85.
23. Singh, P. K.; Behrens, M. E.; Eggers, J. P.; Cerny, R. L.; Bailey, J. M.; Shanmugam, K.; Gendler, S. J.; Bennett, E. P.; Hollingsworth, M. A. Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression. J. Biol. Chem., 2008, 283(40), 26985-26995
24. Kongkham, P. N.; Northcott, P. A.; Ra, Y. S.; Nakahara, Y.; Mainprize, T. G.; Croul, S. E.; Smith, C. A.; Taylor, M. D.; Rutka, J. T. An epigenetic genome-wide screen identifies SPINT2 as a novel tumour suppressor gene in pediatric medulloblastoma. Cancer Res., 2008, 68(23), 9945-9953
25. Matteucci, E.; Bendinelli, P.; Desiderio, M. A., Nuclear localization of active HGF receptor Met in aggressive MDAMB231 breast carcinoma cells. Carcinogenesis, 2009, 30(6), 937-945
26. Eder, J. P.; Vande Woude, G. F.; Boerner, S. A.; LoRusso, P. M. Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin. Cancer Res., 2009, 15(7), 2207-2214
27. Cassinelli, G.; Lanzi, C.; Petrangolini, G.; Tortoreto, M.; Pratesi, G.; Cuccuru, G.; Laccabue, D.; Supino, R.; Belluco, S.; Favini, E.; Poletti, A.; Zunino, F. Inhibition of c-Met and prevention of spontaneous metastatic spreading by the 2-indolinone RPI-1. Mol. Cancer Ther., 2006, 5(9), 2388-2397 (Pubitemid 44530476)